Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

NCT06706284 is registered in ClinicalTrials.gov with Marzieh Salehi as lead sponsor.

NCT NCT06706284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06706284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
Lead sponsor
Marzieh Salehi
Phase
Phase 4
Overall status
Recruiting
Start date
April 11, 2025
Completion date
March 1, 2029
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injuries, type 2 diabetes